WASHINGTON – According to a study paper released Wednesday, a new $56,000-per-year Alzheimer’s drug will hike Medicare rates across the board, and certain patients who are prescribed the prescription might have annual copayments of almost $11,500. The medicine, named Aduhelm, was just recently authorised by the Food and Drug Administration. It’s the first Alzheimer’s drug […]
Read More